Pfizer Jumps Into Obesity Drug Battle With $5 Billion Purchase After Dropping Own Candidate – The Yeshiva World
Five months after ending development of its own obesity treatment, Pfizer is accelerating its push into the rapidly growing field with a nearly $5 billion acquisition. The COVID-19 vaccine and.

